Definium Therapeutics, Inc. Common Shares
€20.3
EUR
Last updated on --.
24h volume1.54M
24h highest20.5135 EUR
24h lowest19.6039 EUR
24h Price movement+2.84%
DFTX recent prices
24 Hours
+2.84%+€0.56095
30 days
+10.63%+€1.950
60 days
+34.46%+€5.203
90 days
+34.84%+€5.247
Key data
Previous close19.7454 EUR
Market cap1.96B EUR
Volume1.54M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.8813 EUR
Net income (FY)-205.00M EUR
Revenue (FY)--
Last report dateMay 7, 2026
About Definium Therapeutics, Inc. Common Shares
HeadquartersNEW YORK
Employees (FY)106.00
Net income per employee (FY)-1.93M EUR
Listed onNasdaq
DFTX conversion tables
 |  |
|---|---|
| 0.5 DFTX | 10.15 EUR |
| 1 DFTX | 20.3 EUR |
| 5 DFTX | 101.53 EUR |
| 10 DFTX | 203.06 EUR |
| |
|---|---|
| 0.5 EUR | 0.024623 DFTX |
| 1 EUR | 0.049246 DFTX |
| 5 EUR | 0.24623 DFTX |
| 10 EUR | 0.49246 DFTX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
DFTX is trading at €20.30, +2.84% over the last 24 hours. Track live moves on the price chart at the top of this page.
The DFTX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. DFTX is currently trading at €20.30, +2.84% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on DFTX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. DFTX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from DFTX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against DFTX's historical range and other companies in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector.
Definium Therapeutics, Inc. Common Shares's market cap is currently 1.96B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.54M
24h highest20.5135 EUR
24h lowest19.6039 EUR
24h Price movement+2.84%
Start trade with DFTX Perpetual
Sign up to trade